128,745 Change 92,046 32,320 7,842 -13,460 364,758 % Change 11.0 11.0 9.8 (14.4) 154.5 In overall, the Company and its subsidiaries had the net profit in the year 2018 at 128.7 MB increased 364.8 MB by
million, whereas Baht 2.59 million in 2018, showing an decrease of Baht 0.83 million or 32.05 % decrease. Overall nearly the same, there is no significant change. Most of them are revenues from interests
in Q2/2017. (Unit: Thousand Baht) Revenues Gross Profit Selling Admin Net(loss) profit Q2/17 222,225 80,232 19,957 22,698 (293,091)*** Q2/18 221,202 78,238 21,637 19,916 35,335 Change -1,023 -1,994
margin was higher as the company could be Revenues Gross Profit Selling Admin Net profit 3Q/17 185,920 62,255 17,599 18,053 19,079 3Q/18 249,407 89,092 21,509 18,502 32,736 Change 63,487 26,837 3,910 449
results for the nine-month period of 2019, change of rate more than 20 percent Dear Director and Manager The Stock Exchange of Thailand According to the resolution of the Board of Directors of DOD Biotech
Stock Exchange of Thailand The Company wishes to present the Management Discussion & Analysis (MD&A) on the operating and financial status for the year 2018. The MD&A would enable the investors to better
Stock Exchange of Thailand The Company wishes to present the Management Discussion & Analysis (MD&A) on the operating and financial status for the year 2017. The MD&A would enable the investors to better
, please provide the information on the change of securities holding as a result of the commencement or termination of status of a concert party or the acquisition or termination of status of a juristic
party or the acquisition or termination of status of a juristic person under Section 258, please provide the information on the change of securities holding as a result of the commencement or termination
commencement or termination of status of a concert party or the acquisition or termination of status of a juristic person under Section 258, please provide the information on the change of securities holding as